Zions Bancorporation, National Association’s Rocket Pharmaceuticals RCKT Stock Holding History

Zions Bancorporation, National Association’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$691	Buy	+202	New	+$672	﹤0.01%	1493

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Zions Bancorporation, National Association's RCKT Position: Q2 2026 in Review

Zions Bancorporation, National Association opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 202 shares worth $691. The stake represents ﹤0.01% of the portfolio and ranks #1493 among its holdings.

180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Zions Bancorporation, National Association held 202 shares of Rocket Pharmaceuticals worth $691 as of Q2 2026.
Rocket Pharmaceuticals was a new Zions Bancorporation, National Association position in Q2 2026.
Rocket Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1493 holding.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.